Gates Foundation – Visterra, Strategic Relationship Letter Agreement Post author:GHIAA Admin Post published:September 19, 2023 Post category: Continue ReadingGates Foundation – Visterra, Strategic Relationship Letter Agreement
Yale University – BIND Biosciences, Cancer Therapeutic, Exclusive License Agreement Post author:GHIAA Admin Post published:March 3, 2023 Post category: Continue ReadingYale University – BIND Biosciences, Cancer Therapeutic, Exclusive License Agreement
DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement Post author:GHIAA Admin Post published:October 26, 2022 Post category: Continue ReadingDNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
Gilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement Post author:GHIAA Admin Post published:September 28, 2022 Post category: Continue ReadingGilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement
AXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement Post author:GHIAA Admin Post published:September 14, 2022 Post category: Continue ReadingAXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement
CARB-X Portfolio Company Agreement Template Post author:GHIAA Admin Post published:August 16, 2022 Post category: Continue ReadingCARB-X Portfolio Company Agreement Template
Shionogi – GARDP, Cefiderocol License Agreement Post author:GHIAA Admin Post published:July 8, 2022 Post category: Continue ReadingShionogi – GARDP, Cefiderocol License Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Admin Post published:March 31, 2022 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement
Fiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement Post author:GHIAA Admin Post published:November 5, 2021 Post category: Continue ReadingFiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement